A detailed history of Cerity Partners LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Cerity Partners LLC holds 580,520 shares of LLY stock, worth $462 Million. This represents 1.15% of its overall portfolio holdings.

Number of Shares
580,520
Previous 530,429 9.44%
Holding current value
$462 Million
Previous $480 Million 7.09%
% of portfolio
1.15%
Previous 1.27%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$772.14 - $960.02 $38.7 Million - $48.1 Million
50,091 Added 9.44%
580,520 $514 Million
Q2 2024

Aug 13, 2024

SELL
$724.87 - $909.04 $12.2 Million - $15.3 Million
-16,841 Reduced 3.08%
530,429 $480 Million
Q1 2024

May 14, 2024

SELL
$592.2 - $792.28 $21 Million - $28.1 Million
-35,491 Reduced 6.09%
547,270 $426 Million
Q4 2023

Jan 26, 2024

BUY
$525.19 - $619.13 $187 Million - $220 Million
355,548 Added 156.48%
582,761 $340 Million
Q3 2023

Nov 13, 2023

SELL
$434.7 - $599.3 $14 Million - $19.3 Million
-32,262 Reduced 12.43%
227,213 $122 Million
Q2 2023

Aug 14, 2023

BUY
$350.74 - $468.98 $8.8 Million - $11.8 Million
25,080 Added 10.7%
259,475 $122 Million
Q1 2023

May 11, 2023

BUY
$310.63 - $364.82 $3.11 Million - $3.65 Million
10,003 Added 4.46%
234,395 $80.5 Million
Q4 2022

Feb 15, 2023

BUY
$321.55 - $374.67 $9.47 Million - $11 Million
29,448 Added 15.11%
224,392 $82.1 Million
Q3 2022

Nov 10, 2022

BUY
$296.48 - $337.87 $1.1 Million - $1.25 Million
3,699 Added 1.93%
194,944 $63 Million
Q2 2022

Aug 10, 2022

BUY
$278.73 - $327.27 $45.2 Million - $53.1 Million
162,110 Added 556.41%
191,245 $62 Million
Q1 2022

Apr 25, 2022

BUY
$234.69 - $291.66 $1.44 Million - $1.79 Million
6,130 Added 26.65%
29,135 $7.5 Million
Q4 2021

Feb 14, 2022

BUY
$224.85 - $279.04 $2.67 Million - $3.31 Million
11,857 Added 106.36%
23,005 $5.62 Million
Q3 2021

Oct 25, 2021

SELL
$221.6 - $272.71 $3,988 - $4,908
-18 Reduced 0.16%
11,148 $2.58 Million
Q2 2021

Aug 11, 2021

SELL
$180.55 - $233.54 $56,873 - $73,565
-315 Reduced 2.74%
11,166 $2.56 Million
Q1 2021

Aug 11, 2021

SELL
$164.32 - $212.72 $148,873 - $192,724
-906 Reduced 7.31%
11,481 $2.15 Million
Q1 2021

May 12, 2021

SELL
$164.32 - $212.72 $187,982 - $243,351
-1,144 Reduced 8.45%
12,387 $2.31 Million
Q4 2020

Feb 11, 2021

BUY
$130.46 - $172.63 $205,996 - $272,582
1,579 Added 13.21%
13,531 $2.29 Million
Q3 2020

Nov 12, 2020

BUY
$146.22 - $169.13 $578,446 - $669,078
3,956 Added 49.47%
11,952 $1.77 Million
Q2 2020

Aug 14, 2020

BUY
$136.42 - $164.18 $54,295 - $65,343
398 Added 5.24%
7,996 $1.31 Million
Q1 2020

May 14, 2020

SELL
$119.05 - $147.35 $43,334 - $53,635
-364 Reduced 4.57%
7,598 $1.06 Million
Q4 2019

Feb 14, 2020

SELL
$106.92 - $132.43 $85,322 - $105,679
-798 Reduced 9.11%
7,962 $1.05 Million
Q3 2019

Oct 30, 2019

BUY
$106.79 - $116.16 $433,887 - $471,958
4,063 Added 86.5%
8,760 $980,000
Q2 2019

Aug 14, 2019

SELL
$110.79 - $129.32 $275,202 - $321,230
-2,484 Reduced 34.59%
4,697 $520,000
Q1 2019

May 14, 2019

SELL
$111.31 - $131.02 $19,034 - $22,404
-171 Reduced 2.33%
7,181 $932,000
Q4 2018

Feb 06, 2019

BUY
$105.9 - $118.64 $19,273 - $21,592
182 Added 2.54%
7,352 $851,000
Q3 2018

Nov 15, 2018

BUY
$85.86 - $107.31 $47,137 - $58,913
549 Added 8.29%
7,170 $769,000
Q2 2018

Aug 15, 2018

BUY
$75.7 - $86.88 $65,556 - $75,238
866 Added 15.05%
6,621 $565,000
Q1 2018

May 15, 2018

SELL
$74.21 - $87.6 $411,346 - $485,566
-5,543 Reduced 49.06%
5,755 $445,000
Q4 2017

Feb 14, 2018

BUY
$81.94 - $87.89 $387,248 - $415,368
4,726 Added 71.91%
11,298 $954,000
Q3 2017

Nov 13, 2017

BUY
$77.07 - $85.54 $506,504 - $562,168
6,572
6,572 $562,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Cerity Partners LLC Portfolio

Follow Cerity Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cerity Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cerity Partners LLC with notifications on news.